41937-02-4

Basic information

• Product Name: BROMBUTEROL
• Synonyms: BROMBUTEROL;BrombuterolHCl;bromobuterol hydrochloride;Brombuterol solution,100ppm;Brombuterol Solution, 1000ppm
• CAS NO: 41937-02-4
• Molecular Formula: C₁₂H₁₈Br₂N₂O
• Molecular Weight: 366.09
• Mol File: 41937-02-4.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 456.2°Cat760mmHg
• Flash Point: 229.7°C
• Appearance: /
• Density: 1.591
• Vapor Pressure: 4.1E-09mmHg at 25°C
• Refractive Index: 1.603
• CAS DataBase Reference: BROMBUTEROL(CAS DataBase Reference)
• NIST Chemistry Reference: BROMBUTEROL(41937-02-4)
• EPA Substance Registry System: BROMBUTEROL(41937-02-4)

Safety Data

• Hazardous Substances Data: 41937-02-4(Hazardous Substances Data)

Usage

Description

Brombuterol is a beta-agonist bronchodilator that is used in the treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). It works by relaxing the smooth muscles in the airways, making it easier to breathe. Brombuterol is also known to have anabolic properties and is sometimes used by athletes and bodybuilders to increase muscle mass and performance. However, the use of brombuterol for non-medical purposes is illegal and can have serious side effects such as tremors, insomnia, and increased heart rate. It is important to use brombuterol only under the supervision of a healthcare professional to minimize the risk of adverse effects.

Uses

Used in Respiratory Treatment:
Brombuterol is used as a bronchodilator for the treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). It helps to relax the smooth muscles in the airways, making it easier for patients to breathe.
Used in Athletic Performance Enhancement:
Brombuterol is used as an anabolic agent by athletes and bodybuilders to increase muscle mass and performance. However, it is important to note that the use of brombuterol for non-medical purposes is illegal and can have serious side effects. It should only be used under the supervision of a healthcare professional to minimize the risk of adverse effects.

InChI:InChI=1/C12H18Br2N2O/c1-12(2,3)16-6-10(17)7-4-8(13)11(15)9(14)5-7/h4-5,10,16-17H,6,15H2,1-3H3

Upstream product

• 99-92-3 p-aminobenzophenone 
• 30095-55-7 4'-amino-2,3',5'-tribromoacetophenone 
• 75-64-9 tert-butylamine 

Relevant articles and documents

Phenylethanolamine β receptor agonist synthetic method

The invention discloses a phenylethanolamine β receptor agonist synthetic method, comprises the following steps: S1: the 4 - amino acetophenone dissolved in an organic solvent, with the electrophilic reagent occurs on the benzene ring substituted halogenated reaction, generating [...] intermediate; [...] intermediates in organic solvent or in water, under the catalysis of the metal catalyst with the cyanide reagent undergo nucleophilic substitution reaction, generating phenyl ketone intermediate; S2: phenyl ketone intermediates in organic solvent, with the copper bromide generating carbonyl α bromo reaction to produce α - bromoacetophenone intermediates; S3: α - bromoacetophenone intermediates in organic solvent with tert-butyl amine or isopropylamine reaction intermediates acetophenone amines; S4: acetophenone amine intermediates in organic solvent, with the reduction hydrogenation reagent react to generate the phenylethanolamine β receptor agonists; synthetic method of this invention a simple and highly efficient and cheap and easy to obtain, atom utilization is high, the synthetic product chemical purity is greater than 99%, to meet the detection requirements of the food safety.

Synthesis of new amino-halogen substituted phenyl-amino ethanols

-